Ullas Mony

Dr. Ullas Mony

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 February 2022 in Polymers
Verified
Journal Article
Open access
PDF file
NYNeena Yadav
Neena Yadav
AFArul Prakash Francis
Arul Prakash Francis
VVVishnu Priya Veeraraghavan
Vishnu Priya Veeraraghavan
Shankargouda PatilShankargouda Patil
Shankargouda Patil
Shazia MushtaqShazia Mushtaq
Shazia Mushtaq
RRRukkumani Rajagopalan
Rukkumani Rajagopalan
Cancer is one of the most widespread deadly diseases, following cardiovascular disease, worldwide. Chemotherapy is widely used in combination with surgery, hormone and radiation therapy to treat various cancers. However, chemotherapeutic drugs can cause severe side effects due to non-specific targeting, poor bioavailability, low therapeutic indices, and high dose requirements. Several drug carriers successfully overcome these issues and deliver drugs to the desired sites, reducing the side effects. Among various drug delivery systems, polysaccharide-based carriers that target only the cancer cells have been developed to overcome the toxicity of chemotherapeutics. Polysaccharides are non-toxic, biodegradable, hydrophilic biopolymers that can be easily modified chemically to improve the bioavailability and stability for delivering therapeutics into cancer tissues. Different polysaccharides, such as chitosan, alginates, cyclodextrin, pullulan, hyaluronic acid, dextran, guar gum, pectin, and cellulose, have been used in anti-cancer drug delivery systems. This review highlights the recent progress made in polysaccharides-based drug carriers in anti-cancer therapy.

29 February 2020 in Tissue Engineering and Regenerative Medicine
Verified
Journal Article
Closed access
PDF file
RNR. J. Nija
R. J. Nija
SSS. Sanju
S. Sanju
NSNeeraj Sidharthan
Neeraj Sidharthan
UMUllas Mony
Ullas Mony

17 January 2020 in Tissue Engineering and Regenerative Medicine
Verified
Journal Article
Closed access
PDF file
SSSiva Sankari Sharath
Siva Sankari Sharath
JRJanarthanan Ramu
Janarthanan Ramu
SNShantikumar Vasudevan Nair
Shantikumar Vasudevan Nair
SISubramaniya Iyer
Subramaniya Iyer
UMUllas Mony
Ullas Mony
Jayakumar RangasamyJayakumar Rangasamy
Jayakumar Rangasamy

4 January 2022 in International Immunopharmacology
Verified
Journal Article
Closed access
MMM. Malavika
M. Malavika
SSS. Sanju
S. Sanju
MPM.R. Poorna
M.R. Poorna
VPVeeraraghavan Vishnu Priya
Veeraraghavan Vishnu Priya
NSNeeraj Sidharthan
Neeraj Sidharthan
UMUllas Mony
Ullas Mony

1 June 2018 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
SVS. Vignesh
S. Vignesh
AGAswathi Gopalakrishnan
Aswathi Gopalakrishnan
PMPoorna M.R.
Poorna M.R.
SNShantikumar V. Nair
Shantikumar V. Nair
Jayakumar RangasamyJayakumar Rangasamy
Jayakumar Rangasamy
UMUllas Mony
Ullas Mony

1 November 2021 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Closed access
MPM.R. Poorna
M.R. Poorna
Jayakumar RangasamyJayakumar Rangasamy
Jayakumar Rangasamy
Jyh-Ping ChenJyh-Ping Chen
Jyh-Ping Chen
UMUllas Mony
Ullas Mony